Epidemiological, Clinical and Laboratory Profile with Treatment Patterns of Autoimmune Bullous Disorders in a Dermatology Department: A Retrospective Study
International Journal of Pharmaceutical Quality Assurance · 30.04.2026 · 17 (4)
DOI: 10.25258/ijpqa.17.4.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 30.04.2026. Verfasst von Asfi Ahmad Zahedi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Autoimmune bullous disorders (ABDs) are rare, chronic mucocutaneous diseases characterized by autoantibody-mediated blister formation and significant morbidity.
Aim
To analyze the epidemiological, clinical, laboratory profile, and treatment patterns of ABDs in a tertiary dermatology department. Methodology: This retrospective observational study at Department of Skin & VD, Sri Krishna Medical College and Hospital, Muzaffarpur, Bihar, India. included 67 patients with histopathology- and direct immunofluorescence-confirmed ABDs. Demographic, clinical, laboratory, comorbidity, therapeutic, and relapse data were extracted from medical records and analyzed using descriptive statistics.
Results
Intraepidermal (n=34) and subepidermal (n=33) diseases were nearly equally distributed. Pemphigus vulgaris (82.4%) predominated among intraepidermal disorders (mean age 48.9 years; M:F 1.25:1), while bullous pemphigoid (72.7%) was most common among subepidermal disorders (mean age 62.8 years; slight female predominance). Hypertension and diabetes were frequent, particularly in subepidermal cases. Azathioprine was the most commonly used adjuvant in both groups. Relapses were more frequent in intraepidermal disorders (35.3% single relapse).
Conclusion
ABDs showed distinct age and comorbidity patterns. Intraepidermal diseases had higher relapse rates, highlighting the need for individualized long-term management.
Zitieren
APA
Zahedi, A. A., Anamika, K., & Satyam, S. (2026). Epidemiological, Clinical and Laboratory Profile with Treatment Patterns of Autoimmune Bullous Disorders in a Dermatology Department: A Retrospective Study. International Journal of Pharmaceutical Quality Assurance, 17(4). https://doi.org/10.25258/ijpqa.17.4.12
Vancouver
Zahedi AA, Anamika K, Satyam S. Epidemiological, Clinical and Laboratory Profile with Treatment Patterns of Autoimmune Bullous Disorders in a Dermatology Department: A Retrospective Study. International Journal of Pharmaceutical Quality Assurance. 2026;17(4). doi:10.25258/ijpqa.17.4.12
BibTeX
@article{Zahedi2026,
author = {Zahedi, Asfi Ahmad and Anamika, Kumari and Satyam, Satyam},
title = {Epidemiological, Clinical and Laboratory Profile with Treatment Patterns of Autoimmune Bullous Disorders in a Dermatology Department: A Retrospective Study},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {4},
doi = {10.25258/ijpqa.17.4.12}
}
EUVIMED